ICON delivers high quality, harmonised data from a global network of laboratories. We work with you to develop strategic, flexible approaches that leverage clinical informatics, state-of-the-art technologies, and our global reach to maximise safety and efficiency and make data-driven decisions for every study.

We bring operational experience, scientific and technical expertise, and a range of innovative tools and ancillary services for sponsors and sites to deliver high quality results. Our central, bioanalytical, and specialty laboratories are located across the US, Singapore, China, The Netherlands and Ireland. All ICON laboratories are CAP accredited, GCP or GLP certified.       

Our bioanalytical laboratories are strategically co-located with ICON’s early phase clinical research units to foster innovative, cross-functional team collaboration and to facilitate the rapid analyses of time-critical samples and support fast dose escalations that are so crucial in today’s adaptive trials.

A global network of ICON-owned central and specialty laboratories use identical analytical platforms, follow standardised SOPs, and report harmonised results directly into a centralised laboratory information management system. All analyses is performed under the strictest standards of accuracy, precision and reproducibility.

ICON’s highly experienced multidisciplinary scientific affairs team will advise sponsors on how to de-risk their clinical trial strategy and optimise the results. Deep expertise across a broad spectrum of testing techniques will give you the support that is vital to the success of your drug development programme. ICON’s range of in-house platforms and assay development expertise in the Bioanalytical and CLIA/CAP Central and Specialty Laboratories assures there are no testing gaps, delivering you full support for your drug development programme.